Phase 1b Double-blind Study to Assess the Safety, Tolerability and Preliminary Efficacy of Resiniferatoxin Versus Placebo for the Treatment of Knee Pain Due to Moderate to Severe Osteoarthritis
Phase of Trial: Phase I
Latest Information Update: 26 Jul 2018
At a glance
- Drugs Resiniferatoxin (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Sorrento Therapeutics
- 18 Jul 2018 Status changed from not yet recruiting to recruiting.
- 31 May 2018 Status changed from planning to not yet recruiting.
- 04 Apr 2018 New trial record